Previous 10 | Next 10 |
home / stock / bmy / bmy articles
Prothena Corporation plc (NASDAQ: PRTA) is reportedly talking to advisors, potentially preparing for a sale. The closely watched Alzheimer'...
The Food and Drug Administration (FDA) approved Pfizer Inc's (NYSE: PFE) Velsipity (etrasimod), an oral, once-daily, selective sphing...
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have hig...
Markets kicked off the week with heightened volatility due to the ongoing conflict between Israel and the Palestinian militant group Hamas. Israel...
Bristol Myers Squibb & Co (NYSE: BMY) has agreed to acquire Mirati Therapeutics Inc (NASDAQ: MRTX) for $58.00 per share in cash,...
The market may open the week on a cautious note due to escalating tensions in the Middle East caused by violent rocket attacks from the Palestinian...
U.S. stock futures traded lower this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session. TPG...
All ten manufacturers of the first drugs selected for Medicare price negotiations will be participating, the White House said, even though many of ...
A U.S. District Judge has upheld a pivotal initiative of President Joe Biden, giving the green light for Medicare to commence negotiations on ...
News, Short Squeeze, Breakout and More Instantly...
Bristol-Myers Squibb Company Company Name:
BMY Stock Symbol:
NYSE Market:
Bristol-Myers Squibb Company Website:
NORTHAMPTON, MA / ACCESSWIRE / July 22, 2024 / Bristol Myers Squibb Company Our Approach to ESG At BMS, we understand that the future of our company, employees, communities, and the planet are inextricably linked. Our passion for making an impact extends beyond the discovery, development a...
The Application is based on Phase 3 CheckMate - 9DW trial results demonstrating improved survival with Opdivo plus Yervoy compared to investigator’s choice of lenvatinib or sorafenib in this patient population Bristol Myers Squibb (NYSE: ...
SBTi validation affirms BMS' long-standing commitment to environmental stewardship PRINCETON, NJ / ACCESSWIRE / July 18, 2024 / Bristol Myers Squibb (NYSE:BMY) today announced validation for its near-term and net-zero science-based targets from the Science Based Targets initiative (SBTi), ...